APO Research
Talk to an analyst

APO RESEARCH · REPORT

Erythropoietin

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

Selected research

Market Analysis & Forecast

Global Erythropoietin Market Analysis and Forecast 2026-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchErythropoietin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Erythropoietin Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Erythropoietin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Erythropoietin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Erythropoietin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

Read the full market overview

The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

This report presents an overview of global market for Erythropoietin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Erythropoietin, also provides the sales of main regions and countries. Of the upcoming market potential for Erythropoietin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Erythropoietin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Erythropoietin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Erythropoietin sales, projected growth trends, production technology, application and end-user industry.

Erythropoietin Segment by Company

Amgen

Johnson & Johnson

Roche

Galenica

Emcure

Kyowa Hakko Kirin

3SBio

Biocon

LG Life Sciences

Erythropoietin Segment by Type

Epoetin-alfa

Epoetin-beta

Darbepoetin-alfa

Others

Erythropoietin Segment by Application

Anemia

Kidney Disorders

Others

Erythropoietin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erythropoietin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Erythropoietin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erythropoietin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Erythropoietin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Erythropoietin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erythropoietin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Erythropoietin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Epoetin-alfa Major Manufacturers Table 3. Epoetin-beta Major Manufacturers Table 4. Darbepoetin-alfa Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Erythropoietin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Anemia Major Manufacturers Table 8. Kidney Disorders Major Manufacturers Table 9. Others Major Manufacturers Table 10. Erythropoietin Industry Trends Table 11. Erythropoietin Industry Drivers Table 12. Erythropoietin Industry Opportunities and Challenges Table 13. Erythropoietin Industry Restraints Table 14. Global Erythropoietin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Erythropoietin Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Erythropoietin Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Erythropoietin Revenue Market Share by Region (2021-2026) Table 18. Global Erythropoietin Revenue Market Share by Region (2027-2032) Table 19. Global Erythropoietin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 20. Global Erythropoietin Sales by Region (2021-2026) & (M Units) Table 21. Global Erythropoietin Sales by Region (2027-2032) & (M Units) Table 22. Global Erythropoietin Sales Market Share by Region (2021-2026) Table 23. Global Erythropoietin Sales Market Share by Region (2027-2032) Table 24. Global Erythropoietin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Erythropoietin Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Erythropoietin Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Erythropoietin Sales Market Share by Manufacturers (2021-2026) Table 28. Global Erythropoietin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Erythropoietin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Erythropoietin Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Erythropoietin Manufacturers, Product Type & Application Table 32. Global Erythropoietin Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Erythropoietin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Erythropoietin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Erythropoietin Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Erythropoietin Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Erythropoietin Revenue Market Share by Type (2021-2026) Table 39. Global Erythropoietin Revenue Market Share by Type (2027-2032) Table 40. Global Erythropoietin Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 41. Global Erythropoietin Sales by Type (2021-2026) & (M Units) Table 42. Global Erythropoietin Sales by Type (2027-2032) & (M Units) Table 43. Global Erythropoietin Sales Market Share by Type (2021-2026) Table 44. Global Erythropoietin Sales Market Share by Type (2027-2032) Table 45. Global Erythropoietin Price by Type (2021-2026) & (US$/Unit) Table 46. Global Erythropoietin Price by Type (2027-2032) & (US$/Unit) Table 47. Global Erythropoietin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Erythropoietin Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Erythropoietin Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Erythropoietin Revenue Market Share by Application (2021-2026) Table 51. Global Erythropoietin Revenue Market Share by Application (2027-2032) Table 52. Global Erythropoietin Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 53. Global Erythropoietin Sales by Application (2021-2026) & (M Units) Table 54. Global Erythropoietin Sales by Application (2027-2032) & (M Units) Table 55. Global Erythropoietin Sales Market Share by Application (2021-2026) Table 56. Global Erythropoietin Sales Market Share by Application (2027-2032) Table 57. Global Erythropoietin Price by Application (2021-2026) & (US$/Unit) Table 58. Global Erythropoietin Price by Application (2027-2032) & (US$/Unit) Table 59. Amgen Company Information Table 60. Amgen Business Overview Table 61. Amgen Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Amgen Erythropoietin Product Portfolio Table 63. Amgen Recent Development Table 64. Johnson & Johnson Company Information Table 65. Johnson & Johnson Business Overview Table 66. Johnson & Johnson Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Johnson & Johnson Erythropoietin Product Portfolio Table 68. Johnson & Johnson Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Roche Erythropoietin Product Portfolio Table 73. Roche Recent Development Table 74. Galenica Company Information Table 75. Galenica Business Overview Table 76. Galenica Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Galenica Erythropoietin Product Portfolio Table 78. Galenica Recent Development Table 79. Emcure Company Information Table 80. Emcure Business Overview Table 81. Emcure Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Emcure Erythropoietin Product Portfolio Table 83. Emcure Recent Development Table 84. Kyowa Hakko Kirin Company Information Table 85. Kyowa Hakko Kirin Business Overview Table 86. Kyowa Hakko Kirin Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Kyowa Hakko Kirin Erythropoietin Product Portfolio Table 88. Kyowa Hakko Kirin Recent Development Table 89. 3SBio Company Information Table 90. 3SBio Business Overview Table 91. 3SBio Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. 3SBio Erythropoietin Product Portfolio Table 93. 3SBio Recent Development Table 94. Biocon Company Information Table 95. Biocon Business Overview Table 96. Biocon Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Biocon Erythropoietin Product Portfolio Table 98. Biocon Recent Development Table 99. LG Life Sciences Company Information Table 100. LG Life Sciences Business Overview Table 101. LG Life Sciences Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. LG Life Sciences Erythropoietin Product Portfolio Table 103. LG Life Sciences Recent Development Table 104. North America Erythropoietin Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Erythropoietin Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Erythropoietin Sales by Type (2021-2026) & (M Units) Table 107. North America Erythropoietin Sales by Type (2027-2032) & (M Units) Table 108. North America Erythropoietin Sales Price by Type (2021-2026) & (US$/Unit) Table 109. North America Erythropoietin Sales Price by Type (2027-2032) & (US$/Unit) Table 110. North America Erythropoietin Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Erythropoietin Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Erythropoietin Sales by Application (2021-2026) & (M Units) Table 113. North America Erythropoietin Sales by Application (2027-2032) & (M Units) Table 114. North America Erythropoietin Sales Price by Application (2021-2026) & (US$/Unit) Table 115. North America Erythropoietin Sales Price by Application (2027-2032) & (US$/Unit) Table 116. North America Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Erythropoietin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Erythropoietin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Erythropoietin Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 120. North America Erythropoietin Sales by Country (2021-2026) & (M Units) Table 121. North America Erythropoietin Sales by Country (2027-2032) & (M Units) Table 122. North America Erythropoietin Sales Price by Country (2021-2026) & (US$/Unit) Table 123. North America Erythropoietin Sales Price by Country (2027-2032) & (US$/Unit) Table 124. United States Erythropoietin Revenue (2021-2032) & (US$ Million) Table 125. Canada Erythropoietin Revenue (2021-2032) & (US$ Million) Table 126. Mexico Erythropoietin Revenue (2021-2032) & (US$ Million) Table 127. Europe Erythropoietin Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Erythropoietin Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Erythropoietin Sales by Type (2021-2026) & (M Units) Table 130. Europe Erythropoietin Sales by Type (2027-2032) & (M Units) Table 131. Europe Erythropoietin Sales Price by Type (2021-2026) & (US$/Unit) Table 132. Europe Erythropoietin Sales Price by Type (2027-2032) & (US$/Unit) Table 133. Europe Erythropoietin Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Erythropoietin Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Erythropoietin Sales by Application (2021-2026) & (M Units) Table 136. Europe Erythropoietin Sales by Application (2027-2032) & (M Units) Table 137. Europe Erythropoietin Sales Price by Application (2021-2026) & (US$/Unit) Table 138. Europe Erythropoietin Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Europe Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Europe Erythropoietin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Europe Erythropoietin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Europe Erythropoietin Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 143. Europe Erythropoietin Sales by Country (2021-2026) & (M Units) Table 144. Europe Erythropoietin Sales by Country (2027-2032) & (M Units) Table 145. Europe Erythropoietin Sales Price by Country (2021-2026) & (US$/Unit) Table 146. Europe Erythropoietin Sales Price by Country (2027-2032) & (US$/Unit) Table 147. Germany Erythropoietin Revenue (2021-2032) & (US$ Million) Table 148. France Erythropoietin Revenue (2021-2032) & (US$ Million) Table 149. U.K. Erythropoietin Revenue (2021-2032) & (US$ Million) Table 150. Italy Erythropoietin Revenue (2021-2032) & (US$ Million) Table 151. Russia Erythropoietin Revenue (2021-2032) & (US$ Million) Table 152. Spain Erythropoietin Revenue (2021-2032) & (US$ Million) Table 153. Netherlands Erythropoietin Revenue (2021-2032) & (US$ Million) Table 154. Switzerland Erythropoietin Revenue (2021-2032) & (US$ Million) Table 155. Sweden Erythropoietin Revenue (2021-2032) & (US$ Million) Table 156. Poland Erythropoietin Revenue (2021-2032) & (US$ Million) Table 157. China Erythropoietin Revenue by Type (2021-2026) & (US$ Million) Table 158. China Erythropoietin Revenue by Type (2027-2032) & (US$ Million) Table 159. China Erythropoietin Sales by Type (2021-2026) & (M Units) Table 160. China Erythropoietin Sales by Type (2027-2032) & (M Units) Table 161. China Erythropoietin Sales Price by Type (2021-2026) & (US$/Unit) Table 162. China Erythropoietin Sales Price by Type (2027-2032) & (US$/Unit) Table 163. China Erythropoietin Revenue by Application (2021-2026) & (US$ Million) Table 164. China Erythropoietin Revenue by Application (2027-2032) & (US$ Million) Table 165. China Erythropoietin Sales by Application (2021-2026) & (M Units) Table 166. China Erythropoietin Sales by Application (2027-2032) & (M Units) Table 167. China Erythropoietin Sales Price by Application (2021-2026) & (US$/Unit) Table 168. China Erythropoietin Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Erythropoietin Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Erythropoietin Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Erythropoietin Sales by Type (2021-2026) & (M Units) Table 172. Asia Erythropoietin Sales by Type (2027-2032) & (M Units) Table 173. Asia Erythropoietin Sales Price by Type (2021-2026) & (US$/Unit) Table 174. Asia Erythropoietin Sales Price by Type (2027-2032) & (US$/Unit) Table 175. Asia Erythropoietin Revenue by Application (2021-2026) & (US$ Million) Table 176. Asia Erythropoietin Revenue by Application (2027-2032) & (US$ Million) Table 177. Asia Erythropoietin Sales by Application (2021-2026) & (M Units) Table 178. Asia Erythropoietin Sales by Application (2027-2032) & (M Units) Table 179. Asia Erythropoietin Sales Price by Application (2021-2026) & (US$/Unit) Table 180. Asia Erythropoietin Sales Price by Application (2027-2032) & (US$/Unit) Table 181. Asia Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia Erythropoietin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. Asia Erythropoietin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. Asia Erythropoietin Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 185. Asia Erythropoietin Sales by Country (2021-2026) & (M Units) Table 186. Asia Erythropoietin Sales by Country (2027-2032) & (M Units) Table 187. Asia Erythropoietin Sales Price by Country (2021-2026) & (US$/Unit) Table 188. Asia Erythropoietin Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Japan Erythropoietin Revenue (2021-2032) & (US$ Million) Table 190. South Korea Erythropoietin Revenue (2021-2032) & (US$ Million) Table 191. India Erythropoietin Revenue (2021-2032) & (US$ Million) Table 192. Australia Erythropoietin Revenue (2021-2032) & (US$ Million) Table 193. Taiwan Erythropoietin Revenue (2021-2032) & (US$ Million) Table 194. Southeast Asia Erythropoietin Revenue (2021-2032) & (US$ Million) Table 195. SAMEA Erythropoietin Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Erythropoietin Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Erythropoietin Sales by Type (2021-2026) & (M Units) Table 198. SAMEA Erythropoietin Sales by Type (2027-2032) & (M Units) Table 199. SAMEA Erythropoietin Sales Price by Type (2021-2026) & (US$/Unit) Table 200. SAMEA Erythropoietin Sales Price by Type (2027-2032) & (US$/Unit) Table 201. SAMEA Erythropoietin Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Erythropoietin Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Erythropoietin Sales by Application (2021-2026) & (M Units) Table 204. SAMEA Erythropoietin Sales by Application (2027-2032) & (M Units) Table 205. SAMEA Erythropoietin Sales Price by Application (2021-2026) & (US$/Unit) Table 206. SAMEA Erythropoietin Sales Price by Application (2027-2032) & (US$/Unit) Table 207. SAMEA Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. SAMEA Erythropoietin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. SAMEA Erythropoietin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. SAMEA Erythropoietin Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 211. SAMEA Erythropoietin Sales by Country (2021-2026) & (M Units) Table 212. SAMEA Erythropoietin Sales by Country (2027-2032) & (M Units) Table 213. SAMEA Erythropoietin Sales Price by Country (2021-2026) & (US$/Unit) Table 214. SAMEA Erythropoietin Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Brazil Erythropoietin Revenue (2021-2032) & (US$ Million) Table 216. Argentina Erythropoietin Revenue (2021-2032) & (US$ Million) Table 217. Chile Erythropoietin Revenue (2021-2032) & (US$ Million) Table 218. Colombia Erythropoietin Revenue (2021-2032) & (US$ Million) Table 219. Peru Erythropoietin Revenue (2021-2032) & (US$ Million) Table 220. Saudi Arabia Erythropoietin Revenue (2021-2032) & (US$ Million) Table 221. Israel Erythropoietin Revenue (2021-2032) & (US$ Million) Table 222. UAE Erythropoietin Revenue (2021-2032) & (US$ Million) Table 223. Turkey Erythropoietin Revenue (2021-2032) & (US$ Million) Table 224. Iran Erythropoietin Revenue (2021-2032) & (US$ Million) Table 225. Egypt Erythropoietin Revenue (2021-2032) & (US$ Million) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Erythropoietin Distributors List Table 229. Erythropoietin Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Erythropoietin Image Figure 2. Global Erythropoietin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Erythropoietin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Epoetin-alfa Image Figure 5. Epoetin-beta Image Figure 6. Darbepoetin-alfa Image Figure 7. Others Image Figure 8. Global Erythropoietin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Erythropoietin Market Size Share 2021 VS 2025 VS 2032 Figure 10. Anemia Image Figure 11. Kidney Disorders Image Figure 12. Others Image Figure 13. Global Erythropoietin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Erythropoietin Revenue (2021-2032) & (US$ Million) Figure 15. Global Erythropoietin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Erythropoietin Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Erythropoietin Revenue Market Share by Region (2021-2032) Figure 18. Global Erythropoietin Sales (2021-2032) & (M Units) Figure 19. Global Erythropoietin Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 20. Global Erythropoietin Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Erythropoietin Sales YoY (2021-2032) & (M Units) Figure 22. Europe Erythropoietin Sales YoY (2021-2032) & (M Units) Figure 23. China Erythropoietin Sales YoY (2021-2032) & (M Units) Figure 24. Asia (Excluding China) Erythropoietin Sales YoY (2021-2032) & (M Units) Figure 25. South America, Middle East and Africa Erythropoietin Sales YoY (2021-2032) & (M Units) Figure 26. Global Erythropoietin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Erythropoietin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Erythropoietin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Erythropoietin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Erythropoietin Revenue Market Share by Type (2021-2032) Figure 32. Global Erythropoietin Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 33. Global Erythropoietin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Erythropoietin Sales Market Share by Type (2021-2032) Figure 35. Global Erythropoietin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Erythropoietin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Erythropoietin Revenue Market Share by Application (2021-2032) Figure 38. Global Erythropoietin Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 39. Global Erythropoietin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Erythropoietin Sales Market Share by Application (2021-2032) Figure 41. North America Erythropoietin Revenue Share by Type (2021-2032) Figure 42. North America Erythropoietin Sales Share by Type (2021-2032) Figure 43. North America Erythropoietin Revenue Share by Application (2021-2032) Figure 44. North America Erythropoietin Sales Share by Application (2021-2032) Figure 45. North America Erythropoietin Revenue Share by Country (2021-2032) Figure 46. North America Erythropoietin Sales Share by Country (2021-2032) Figure 47. Europe Erythropoietin Revenue Share by Type (2021-2032) Figure 48. Europe Erythropoietin Sales Share by Type (2021-2032) Figure 49. Europe Erythropoietin Revenue Share by Application (2021-2032) Figure 50. Europe Erythropoietin Sales Share by Application (2021-2032) Figure 51. Europe Erythropoietin Revenue Share by Country (2021-2032) Figure 52. Europe Erythropoietin Sales Share by Country (2021-2032) Figure 53. China Erythropoietin Revenue Share by Type (2021-2032) Figure 54. China Erythropoietin Sales Share by Type (2021-2032) Figure 55. China Erythropoietin Revenue Share by Application (2021-2032) Figure 56. China Erythropoietin Sales Share by Application (2021-2032) Figure 57. Asia Erythropoietin Revenue Share by Type (2021-2032) Figure 58. Asia Erythropoietin Sales Share by Type (2021-2032) Figure 59. Asia Erythropoietin Revenue Share by Application (2021-2032) Figure 60. Asia Erythropoietin Sales Share by Application (2021-2032) Figure 61. Asia Erythropoietin Revenue Share by Country (2021-2032) Figure 62. Asia Erythropoietin Sales Share by Country (2021-2032) Figure 63. SAMEA Erythropoietin Revenue Share by Type (2021-2032) Figure 64. SAMEA Erythropoietin Sales Share by Type (2021-2032) Figure 65. SAMEA Erythropoietin Revenue Share by Application (2021-2032) Figure 66. SAMEA Erythropoietin Sales Share by Application (2021-2032) Figure 67. SAMEA Erythropoietin Revenue Share by Country (2021-2032) Figure 68. SAMEA Erythropoietin Sales Share by Country (2021-2032) Figure 69. Erythropoietin Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Erythropoietin Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others
Applications
  • Anemia
  • Kidney Disorders
  • Others
Companies covered
  • Amgen
  • Johnson & Johnson
  • Roche
  • Galenica
  • Emcure
  • Kyowa Hakko Kirin
  • 3SBio
  • Biocon
  • LG Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Erythropoietin Market by Type
  3. 1.2.1 Global Erythropoietin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Epoetin-alfa
  5. 1.2.3 Epoetin-beta
  6. 1.2.4 Darbepoetin-alfa
  7. 1.2.5 Others
  8. 1.3 Erythropoietin Market by Application
  9. 1.3.1 Global Erythropoietin Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Anemia
  11. 1.3.3 Kidney Disorders
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Erythropoietin Market Dynamics
  1. 2.1 Erythropoietin Industry Trends
  2. 2.2 Erythropoietin Industry Drivers
  3. 2.3 Erythropoietin Industry Opportunities and Challenges
  4. 2.4 Erythropoietin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Erythropoietin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Erythropoietin Revenue by Region
  3. 3.2.1 Global Erythropoietin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Erythropoietin Revenue by Region (2021-2026)
  5. 3.2.3 Global Erythropoietin Revenue by Region (2027-2032)
  6. 3.2.4 Global Erythropoietin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Erythropoietin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Erythropoietin Sales by Region
  9. 3.4.1 Global Erythropoietin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Erythropoietin Sales by Region (2021-2026)
  11. 3.4.3 Global Erythropoietin Sales by Region (2027-2032)
  12. 3.4.4 Global Erythropoietin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Erythropoietin Revenue by Manufacturers
  2. 4.1.1 Global Erythropoietin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Erythropoietin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Erythropoietin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Erythropoietin Sales by Manufacturers
  6. 4.2.1 Global Erythropoietin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Erythropoietin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Erythropoietin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Erythropoietin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Erythropoietin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Erythropoietin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Erythropoietin Manufacturers, Product Type & Application
  13. 4.7 Global Erythropoietin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Erythropoietin Market CR5 and HHI
  16. 4.8.2 2025 Erythropoietin Tier 1, Tier 2, and Tier 3
5 Erythropoietin Market by Type
  1. 5.1 Global Erythropoietin Revenue by Type
  2. 5.1.1 Global Erythropoietin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Erythropoietin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Erythropoietin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Erythropoietin Sales by Type
  6. 5.2.1 Global Erythropoietin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Erythropoietin Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Erythropoietin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Erythropoietin Price by Type
6 Erythropoietin Market by Application
  1. 6.1 Global Erythropoietin Revenue by Application
  2. 6.1.1 Global Erythropoietin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Erythropoietin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Erythropoietin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Erythropoietin Sales by Application
  6. 6.2.1 Global Erythropoietin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Erythropoietin Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Erythropoietin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Erythropoietin Price by Application
7 Company Profiles
  1. 7.1 Amgen
  2. 7.1.1 Amgen Company Information
  3. 7.1.2 Amgen Business Overview
  4. 7.1.3 Amgen Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amgen Erythropoietin Product Portfolio
  6. 7.1.5 Amgen Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Erythropoietin Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Roche Erythropoietin Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Galenica
  20. 7.4.1 Galenica Company Information
  21. 7.4.2 Galenica Business Overview
  22. 7.4.3 Galenica Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Galenica Erythropoietin Product Portfolio
  24. 7.4.5 Galenica Recent Developments
  25. 7.5 Emcure
  26. 7.5.1 Emcure Company Information
  27. 7.5.2 Emcure Business Overview
  28. 7.5.3 Emcure Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Emcure Erythropoietin Product Portfolio
  30. 7.5.5 Emcure Recent Developments
  31. 7.6 Kyowa Hakko Kirin
  32. 7.6.1 Kyowa Hakko Kirin Company Information
  33. 7.6.2 Kyowa Hakko Kirin Business Overview
  34. 7.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kyowa Hakko Kirin Erythropoietin Product Portfolio
  36. 7.6.5 Kyowa Hakko Kirin Recent Developments
  37. 7.7 3SBio
  38. 7.7.1 3SBio Company Information
  39. 7.7.2 3SBio Business Overview
  40. 7.7.3 3SBio Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 3SBio Erythropoietin Product Portfolio
  42. 7.7.5 3SBio Recent Developments
  43. 7.8 Biocon
  44. 7.8.1 Biocon Company Information
  45. 7.8.2 Biocon Business Overview
  46. 7.8.3 Biocon Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biocon Erythropoietin Product Portfolio
  48. 7.8.5 Biocon Recent Developments
  49. 7.9 LG Life Sciences
  50. 7.9.1 LG Life Sciences Company Information
  51. 7.9.2 LG Life Sciences Business Overview
  52. 7.9.3 LG Life Sciences Erythropoietin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 LG Life Sciences Erythropoietin Product Portfolio
  54. 7.9.5 LG Life Sciences Recent Developments
8 North America
  1. 8.1 North America Erythropoietin Market Size by Type
  2. 8.1.1 North America Erythropoietin Revenue by Type (2021-2032)
  3. 8.1.2 North America Erythropoietin Sales by Type (2021-2032)
  4. 8.1.3 North America Erythropoietin Price by Type (2021-2032)
  5. 8.2 North America Erythropoietin Market Size by Application
  6. 8.2.1 North America Erythropoietin Revenue by Application (2021-2032)
  7. 8.2.2 North America Erythropoietin Sales by Application (2021-2032)
  8. 8.2.3 North America Erythropoietin Price by Application (2021-2032)
  9. 8.3 North America Erythropoietin Market Size by Country
  10. 8.3.1 North America Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Erythropoietin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Erythropoietin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Erythropoietin Market Size by Type
  2. 9.1.1 Europe Erythropoietin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Erythropoietin Sales by Type (2021-2032)
  4. 9.1.3 Europe Erythropoietin Price by Type (2021-2032)
  5. 9.2 Europe Erythropoietin Market Size by Application
  6. 9.2.1 Europe Erythropoietin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Erythropoietin Sales by Application (2021-2032)
  8. 9.2.3 Europe Erythropoietin Price by Application (2021-2032)
  9. 9.3 Europe Erythropoietin Market Size by Country
  10. 9.3.1 Europe Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Erythropoietin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Erythropoietin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Erythropoietin Market Size by Type
  2. 10.1.1 China Erythropoietin Revenue by Type (2021-2032)
  3. 10.1.2 China Erythropoietin Sales by Type (2021-2032)
  4. 10.1.3 China Erythropoietin Price by Type (2021-2032)
  5. 10.2 China Erythropoietin Market Size by Application
  6. 10.2.1 China Erythropoietin Revenue by Application (2021-2032)
  7. 10.2.2 China Erythropoietin Sales by Application (2021-2032)
  8. 10.2.3 China Erythropoietin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Erythropoietin Market Size by Type
  2. 11.1.1 Asia Erythropoietin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Erythropoietin Sales by Type (2021-2032)
  4. 11.1.3 Asia Erythropoietin Price by Type (2021-2032)
  5. 11.2 Asia Erythropoietin Market Size by Application
  6. 11.2.1 Asia Erythropoietin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Erythropoietin Sales by Application (2021-2032)
  8. 11.2.3 Asia Erythropoietin Price by Application (2021-2032)
  9. 11.3 Asia Erythropoietin Market Size by Country
  10. 11.3.1 Asia Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Erythropoietin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Erythropoietin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Erythropoietin Market Size by Type
  2. 12.1.1 SAMEA Erythropoietin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Erythropoietin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Erythropoietin Price by Type (2021-2032)
  5. 12.2 SAMEA Erythropoietin Market Size by Application
  6. 12.2.1 SAMEA Erythropoietin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Erythropoietin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Erythropoietin Price by Application (2021-2032)
  9. 12.3 SAMEA Erythropoietin Market Size by Country
  10. 12.3.1 SAMEA Erythropoietin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Erythropoietin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Erythropoietin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Erythropoietin Value Chain Analysis
  2. 13.1.1 Erythropoietin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Erythropoietin Production Mode & Process
  6. 13.2 Erythropoietin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Erythropoietin Distributors
  9. 13.2.3 Erythropoietin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst